Although a great deal of preclinical data (44–46) support the important contribution of the CCL2-CCR2 axis in experimental cardiovascular disease, the existing clinical studies (47, 48) have not yielded satisfactory results. This evidence concerns the gene CCR2 and cardiovascular disorder.